“Proteomics expects to meet with the FDA to progress its clearance within 10 weeks. If PromarkerD gains FDA approval, the company will be able to deploy its easy-to-use, inexpensive blood test throughout the United States.”
Article: Proteomics International (ASX:PIQ) pursues FDA approval for PromarkerD